Provider
QP50-25 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2025
Program effective Date: Jun 11, 2025
Search Results
Displaying 2901 - 2910 of 4204 results
Provider
QP49-25 MHCP Pharmacy Benefit Exclusion for Imaavy™, Lutrate Depot®, Tepylute, Ustekinumab and Ustekinumab-aekn
Program effective Date: Jun 11, 2025
Provider
QP48-25 Commercial Pharmacy Benefit Exclusion for Imaavy™, Ustekinumab and Ustekinumab-aekn
Program effective Date: Jun 11, 2025
Provider
QP47-25 Updated Accessibility Requirements
Program effective Date: Jun 11, 2025
Provider
QP54-25 “Serious Illness Conversations: Improving Patient Care at End of Life” Training Available July/August 2025
Program effective Date: Jun 25, 2025
Provider
QP53-25 Update for New-to-Market Medical Drugs: nipocalimab-aahu
Program effective Date: Jun 25, 2025